New research links noninvasive brain blood flow and oxygenation markers to hallmark Alzheimer's disease changes, suggesting early risk detection potential.
Key Details
- 1Study conducted at the Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC.
- 2Researchers used transcranial Doppler ultrasound and near-infrared spectroscopy to measure brain blood flow and oxygenation.
- 3Findings associated higher vascular function indicators with lower amyloid plaques and larger hippocampal volume.
- 4Amyloid PET imaging was also used to correlate vascular markers with known AD pathology.
- 5Techniques are less costly and more tolerable for large-scale or difficult-to-image populations than MRI or PET.
- 6Longitudinal studies are underway to assess if changes in these markers can predict cognitive decline.
Why It Matters
Demonstrating a link between vascular brain health (measured noninvasively) and established Alzheimer’s imaging findings could enable earlier and easier risk stratification. The use of noninvasive, accessible tools may facilitate broad screening and intervention research in populations unable to tolerate extensive imaging.
Source
EurekAlert
Related News
•EurekAlert
AI Pathology Tool SÉMIL Improves Stage II Bowel Cancer Risk Assessment
A La Trobe University-developed AI tool accurately predicts relapse risk in stage II bowel cancer using digital pathology images and descriptions.
•EurekAlert
AI Tool Predicts Which Rectal Cancer Patients Benefit from Intensive Therapy
UCL researchers developed an AI that analyzes biopsy slides to identify rectal cancer patients who benefit from adding irinotecan to standard chemoradiotherapy.
•EurekAlert
AI-Guided Handheld Cardiac Ultrasound Reduces Referrals and Costs in Spain
AI-guided handheld cardiac ultrasound enables primary care physicians to detect heart failure, reducing specialist referrals and saving costs.